Literature DB >> 30561514

Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions.

Ulrike W Kaunzner1, Yeona Kang2, Shun Zhang3, Eric Morris1, Yihao Yao3, Sneha Pandya2, Sandra M Hurtado Rua4, Calvin Park5, Kelly M Gillen3, Thanh D Nguyen3, Yi Wang3, David Pitt5, Susan A Gauthier1.   

Abstract

Chronic active multiple sclerosis lesions, characterized by a hyperintense rim of iron-enriched, activated microglia and macrophages, have been linked to greater tissue damage. Post-mortem studies have determined that chronic active lesions are primarily related to the later stages of multiple sclerosis; however, the occurrence of these lesions, and their relationship to earlier disease stages may be greatly underestimated. Detection of chronic active lesions across the patient spectrum of multiple sclerosis requires a validated imaging tool to accurately identify lesions with persistent inflammation. Quantitative susceptibility mapping provides efficient in vivo quantification of susceptibility changes related to iron deposition and the potential to identify lesions harbouring iron-laden inflammatory cells. The PET tracer 11C-PK11195 targets the translocator protein expressed by activated microglia and infiltrating macrophages. Accordingly, this study aimed to validate that lesions with a hyperintense rim on quantitative susceptibility mapping from both relapsing and progressive patients demonstrate a higher level of innate immune activation as measured on 11C-PK11195 PET. Thirty patients were enrolled in this study, 24 patients had relapsing remitting multiple sclerosis, six had progressive multiple sclerosis, and all patients had concomitant MRI with a gradient echo sequence and PET with 11C-PK11195. A total of 406 chronic lesions were detected, and 43 chronic lesions with a hyperintense rim on quantitative susceptibility mapping were identified as rim+ lesions. Susceptibility (relative to CSF) was higher in rim+ (2.42 ± 17.45 ppb) compared to rim- lesions (-14.6 ± 19.3 ppb, P < 0.0001). Among rim+ lesions, susceptibility within the rim (20.04 ± 14.28 ppb) was significantly higher compared to the core (-5.49 ± 14.44 ppb, P < 0.0001), consistent with the presence of iron. In a mixed-effects model, 11C-PK11195 uptake, representing activated microglia/macrophages, was higher in rim+ lesions compared to rim- lesions (P = 0.015). Validating our in vivo imaging results, multiple sclerosis brain slabs were imaged with quantitative susceptibility mapping and processed for immunohistochemistry. These results showed a positive translocator protein signal throughout the expansive hyperintense border of rim+ lesions, which co-localized with iron containing CD68+ microglia and macrophages. In conclusion, this study provides evidence that suggests that a hyperintense rim on quantitative susceptibility measure within a chronic lesion is a correlate for persistent inflammatory activity and that these lesions can be identified in the relapsing patients. Utilizing quantitative susceptibility measure to differentiate chronic multiple sclerosis lesion subtypes, especially chronic active lesions, would provide a method to assess the impact of these lesions on disease progression.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30561514      PMCID: PMC6308309          DOI: 10.1093/brain/awy296

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  63 in total

1.  Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron.

Authors:  Kathryn E Hammond; Meredith Metcalf; Lucas Carvajal; Darin T Okuda; Radhika Srinivasan; Dan Vigneron; Sarah J Nelson; Daniel Pelletier
Journal:  Ann Neurol       Date:  2008-12       Impact factor: 10.422

2.  Calculation of susceptibility through multiple orientation sampling (COSMOS): a method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in MRI.

Authors:  Tian Liu; Pascal Spincemaille; Ludovic de Rochefort; Bryan Kressler; Yi Wang
Journal:  Magn Reson Med       Date:  2009-01       Impact factor: 4.668

Review 3.  Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: trends and advances.

Authors:  Kritika Goyal; Veena Koul; Yashveer Singh; Akshay Anand
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2014

Review 4.  Imaging Microglial Activation with TSPO PET: Lighting Up Neurologic Diseases?

Authors:  Lucy Vivash; Terence J O'Brien
Journal:  J Nucl Med       Date:  2015-12-23       Impact factor: 10.057

5.  Reproducibility of quantitative susceptibility mapping in the brain at two field strengths from two vendors.

Authors:  Kofi Deh; Thanh D Nguyen; Sarah Eskreis-Winkler; Martin R Prince; Pascal Spincemaille; Susan Gauthier; Ilhami Kovanlikaya; Yan Zhang; Yi Wang
Journal:  J Magn Reson Imaging       Date:  2015-05-09       Impact factor: 4.813

6.  Lesion Heterogeneity on High-Field Susceptibility MRI Is Associated with Multiple Sclerosis Severity.

Authors:  D M Harrison; X Li; H Liu; C K Jones; B Caffo; P A Calabresi; P van Zijl
Journal:  AJNR Am J Neuroradiol       Date:  2016-03-03       Impact factor: 3.825

7.  Seven-tesla phase imaging of acute multiple sclerosis lesions: a new window into the inflammatory process.

Authors:  Martina Absinta; Pascal Sati; María I Gaitán; Pietro Maggi; Irene C M Cortese; Massimo Filippi; Daniel S Reich
Journal:  Ann Neurol       Date:  2013-09-16       Impact factor: 10.422

Review 8.  Pathology of multiple sclerosis: where do we stand?

Authors:  Bogdan F Gh Popescu; Istvan Pirko; Claudia F Lucchinetti
Journal:  Continuum (Minneap Minn)       Date:  2013-08

9.  Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS.

Authors:  Benedetta Parodi; Silvia Rossi; Sara Morando; Christian Cordano; Alberto Bragoni; Caterina Motta; Cesare Usai; Brian T Wipke; Robert H Scannevin; Giovanni L Mancardi; Diego Centonze; Nicole Kerlero de Rosbo; Antonio Uccelli
Journal:  Acta Neuropathol       Date:  2015-04-29       Impact factor: 17.088

10.  Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging.

Authors:  Assunta Dal-Bianco; Günther Grabner; Claudia Kronnerwetter; Michael Weber; Romana Höftberger; Thomas Berger; Eduard Auff; Fritz Leutmezer; Siegfried Trattnig; Hans Lassmann; Francesca Bagnato; Simon Hametner
Journal:  Acta Neuropathol       Date:  2016-10-27       Impact factor: 17.088

View more
  46 in total

1.  Sex-specific differences in rim appearance of multiple sclerosis lesions on quantitative susceptibility mapping.

Authors:  Tolaymat B; Zheng W; Chen H; Choi S; Li X; Harrison Dm
Journal:  Mult Scler Relat Disord       Date:  2020-06-18       Impact factor: 4.339

2.  Quantitative Susceptibility Mapping of Time-Dependent Susceptibility Changes in Multiple Sclerosis Lesions.

Authors:  S Zhang; T D Nguyen; S M Hurtado Rúa; U W Kaunzner; S Pandya; I Kovanlikaya; P Spincemaille; Y Wang; S A Gauthier
Journal:  AJNR Am J Neuroradiol       Date:  2019-05-16       Impact factor: 3.825

3.  Predictive value of thrombus susceptibility for cardioembolic stroke by quantitative susceptibility mapping.

Authors:  Jie Chen; Zhe Zhang; Ximing Nie; Yuyuan Xu; Chunlei Liu; Xingquan Zhao; Yongjun Wang
Journal:  Quant Imaging Med Surg       Date:  2022-01

4.  Clinical Integration of Automated Processing for Brain Quantitative Susceptibility Mapping: Multi-Site Reproducibility and Single-Site Robustness.

Authors:  Pascal Spincemaille; Zhe Liu; Shun Zhang; Ilhami Kovanlikaya; Matteo Ippoliti; Marcus Makowski; Richard Watts; Ludovic de Rochefort; Vijay Venkatraman; Patricia Desmond; Mathieu D Santin; Stéphane Lehéricy; Brian H Kopell; Patrice Péran; Yi Wang
Journal:  J Neuroimaging       Date:  2019-08-04       Impact factor: 2.486

5.  Patterning Chronic Active Demyelination in Slowly Expanding/Evolving White Matter MS Lesions.

Authors:  C Elliott; D L Arnold; H Chen; C Ke; L Zhu; I Chang; E Cahir-McFarland; E Fisher; B Zhu; S Gheuens; M Scaramozza; V Beynon; N Franchimont; D P Bradley; S Belachew
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-20       Impact factor: 3.825

6.  Simultaneous QSM and metabolic imaging of the brain using SPICE: Further improvements in data acquisition and processing.

Authors:  Rong Guo; Yibo Zhao; Yudu Li; Tianyao Wang; Yao Li; Brad Sutton; Zhi-Pei Liang
Journal:  Magn Reson Med       Date:  2020-08-18       Impact factor: 4.668

7.  Basilar artery thrombus magnetic susceptibility for cardioembolic stroke identification.

Authors:  Jie Chen; Zhe Zhang; Ximing Nie; Yuyuan Xu; Chunlei Liu; Xingquan Zhao; Yongjun Wang
Journal:  Quant Imaging Med Surg       Date:  2022-02

8.  SWI as an Alternative to Contrast-Enhanced Imaging to Detect Acute MS Lesions.

Authors:  G Caruana; C Auger; L M Pessini; W Calderon; A de Barros; A Salerno; J Sastre-Garriga; X Montalban; À Rovira
Journal:  AJNR Am J Neuroradiol       Date:  2022-03-24       Impact factor: 3.825

9.  In Vivo Proton Exchange Rate (kex ) MRI for the Characterization of Multiple Sclerosis Lesions in Patients.

Authors:  Haiqi Ye; Mehran Shaghaghi; Qianlan Chen; Yan Zhang; Sarah E Lutz; Weiwei Chen; Kejia Cai
Journal:  J Magn Reson Imaging       Date:  2020-09-24       Impact factor: 4.813

10.  A Multi-Ligand Imaging Study Exploring GABAergic Receptor Expression and Inflammation in Multiple Sclerosis.

Authors:  Yeona Kang; Sandra Milena Hurtado Rúa; Ulrike W Kaunzner; Jai Perumal; Nancy Nealon; Wenchao Qu; Paresh J Kothari; Timothy Vartanian; Amy Kuceyeski; Susan A Gauthier
Journal:  Mol Imaging Biol       Date:  2020-12       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.